Glia · 2022 · 15 citations · 44 references
Life SciencesMolecular BiologyPharmacologyCell SignalingLipid BiochemistrySignal TransductionCell Membrane StructureCell-surface ReceptorsLigand BindingLipid Bilayer StructureLipid-protein InteractionsReceptor-ligand InteractionsLiposome CharacterizationLiposome StructureLiposomesReceptor DimerizationStalk Domain StructureStimuli-responsive LiposomesStructure - Activity Relationship OptimizationTargeted Liposomes
The receptor Triggering Receptor Expressed on Myeloid cells 2 (TREM2) is associated with several neurodegenerative diseases including Alzheimer's Disease and TREM2 stimulation represents a novel therapeutic opportunity. TREM2 can be activated by antibodies targeting the stalk region, most likely through receptor dimerization. Endogenous ligands of TREM2 are suggested to be negatively charged apoptotic bodies, mimicked by phosphatidylserine incorporated in liposomes and other polyanionic molecules likely binding to TREM2 IgV fold. However, there has been much discrepancy in the literature on the nature of phospholipids (PLs) that can activate TREM2 and on the stability of the corresponding liposomes over time. We describe optimized liposomes as robust agonists selective for TREM2 over TREM1 in cellular system. The detailed structure/activity relationship studies of lipid polar heads indicate that negatively charged lipid heads are required for activity and we identified the shortest maximally active PL sidechain. Optimized liposomes are active on both TREM2 common variant and TREM2 R47H mutant. Activity and selectivity were further confirmed in different native TREM2 expressing cell types including on integrated cellular responses such as stimulation of phagocytic activity. Such tool agonists will be useful in further studies of TREM2 biology in cellular systems alongside antibodies, and in the design of small molecule synthetic TREM2 agonists.
44
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Hadas Keren‐Shaul, Amit Spinrad, Assaf Weiner et al. · Cell · 2017 · 5.6K citations · Full text
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Yaming Wang, Marina Cella, Kaitlin Mallinson et al. · Cell · 2015 · 1.8K citations · Full text
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Tyler K. Ulland, Wilbur M. Song, Stanley Ching‐Cheng Huang et al. · Cell · 2017 · 1.3K citations · Full text